Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: An open‐label trial

OBJECTIVE: To evaluate the pharmacokinetics, safety, and tolerability of brivaracetam (BRV) as 15‐min intravenous (IV) infusion and bolus (≤2‐min injection). METHODS: EP0065 (ClinicalTrials.gov: NCT03405714) was a Phase 2, multicenter, open‐label trial in patients ≥1 month to <16 years of age wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Farkas, Mark Kristof, Kang, Harriet, Fogarasi, Andras, Bozorg, Ali, James, Gareth D., Krauwinkel, Walter, Morita, Diego, Will, Edgar, Elshoff, Jan‐Peer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303197/
https://www.ncbi.nlm.nih.gov/pubmed/35196395
http://dx.doi.org/10.1111/epi.17187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303197/
https://www.ncbi.nlm.nih.gov/pubmed/35196395
http://dx.doi.org/10.1111/epi.17187

Ejemplares similares